0 Комментарии
0 Поделились
897 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Autoimmune Polyglandular Syndrome Type 1 Market Forecasted to Reach $363M by 2032Introspective Market Research (IMR) today announced the release of its Autoimmune Polyglandular Syndrome Type 1 (APS-1) Market Report, projecting a consistent expansion in this rare but clinically significant autoimmune disorder. IMR’s analysis estimates that the APS-1 market — recently valued at USD 289.1 million (2025) according to — will grow to approximately USD...0 Комментарии 0 Поделились 842 Просмотры 0 предпросмотр
-
Campomelic Syndrome Treatment Market - Overview and Outlook by Potential GrowthIntrospective Market Research, a leader in pharmaceutical and healthcare intelligence, today published its deep-dive analysis into the Global Campomelic Syndrome Treatment Market. Campomelic Syndrome (CS) is a rare and often life-threatening genetic disorder characterized by severe skeletal malformations, which necessitates intensive supportive and specialized care. The market, which focuses on...0 Комментарии 0 Поделились 870 Просмотры 0 предпросмотр
-
Global Parkinson’s Disease Treatment Market Grows with Advancements in Therapeutics"Executive Summary: Parkinson’s Disease Treatment Market Size and Share by Application & Industry Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period. In the leading...0 Комментарии 0 Поделились 584 Просмотры 0 предпросмотр
-
How Is Innovation Shaping the Global Parkinson’s Disease Treatment Market?"Executive Summary: Parkinson’s Disease Treatment Market Size and Share by Application & Industry Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period. In the leading...0 Комментарии 0 Поделились 482 Просмотры 0 предпросмотр
-
Influenza Drug Market Strengthens with Growing Focus on Viral Disease Management"Executive Summary Influenza Drug Market Size and Share: Global Industry Snapshot The global influenza drug market size was valued at USD 981.68 billion in 2024 and is expected to reach USD 1,168.36 billion by 2032, at a CAGR of 2.20% during the forecast period The research and analysis carried out in this Influenza Drug report helps clients to...0 Комментарии 0 Поделились 420 Просмотры 0 предпросмотр
-
Is RNA Therapeutics Revolutionizing the Next Generation of Disease Treatment?"Global Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine While preparing the first class RNA...0 Комментарии 0 Поделились 504 Просмотры 0 предпросмотр
-
Osteogenesis Imperfecta Treatment Market - Trend, Growth, Forecast 2024–2032Introspective Market Research (IMR) has unveiled its latest strategic analysis on the Global Osteogenesis Imperfecta (OI) Treatment Market. The report highlights the critical role of specialized pharmaceuticals and emerging gene therapies in managing this rare, inherited connective tissue disorder, often referred to as "brittle bone disease." The market, which was valued at USD 722.9 Million in...0 Комментарии 0 Поделились 916 Просмотры 0 предпросмотр
-
Parkinson’s Disease Treatment Market Advances with Novel Therapies and Improved Patient CareExecutive Summary Parkinson’s Disease Treatment Market Size and Share Forecast Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period. Parkinson’s Disease Treatment Market report...0 Комментарии 0 Поделились 182 Просмотры 0 предпросмотр
-
Parkinson’s Disease Treatment Market Progresses with Advancements in TherapeuticsExecutive Summary: Parkinson’s Disease Treatment Market Size and Share by Application & Industry Data Bridge Market Research analyses that the Parkinson’s disease treatment market which was USD 4,999.18 million in 2022, would rocket up to USD 10,034.52 million by 2030, and is expected to undergo a CAGR of 9.10% during the forecast period. In the leading...0 Комментарии 0 Поделились 358 Просмотры 0 предпросмотр
-
Phenylketonuria Treatment Market Advances with Innovations in Rare Disease TherapiesExecutive Summary Phenylketonuria (PKU) Treatment Market: Share, Size & Strategic Insights The rise in the research in the field of genomics and bioinformatics and rise in the awareness amongst the people across the globe is expected to accelerate the market growth in the forecast period of 2022 to 2029. Phenylketonuria (PKU) Treatment Market research report works best for the...0 Комментарии 0 Поделились 118 Просмотры 0 предпросмотр
-
Primary Biliary Cholangitis Treatment Market - Comprehensive Study Report & Recent Trends 2024-2032Introspective Market Research (IMR) has published a new report highlighting the robust expansion of the Global Primary Biliary Cholangitis (PBC) Treatment Market. Driven by increasing awareness, improved diagnostic tools, and the introduction of advanced pharmacotherapies, the market is set for significant growth. Valued at USD 0.6 Billion in 2023, the PBC Treatment Market is forecasted to...0 Комментарии 0 Поделились 930 Просмотры 0 предпросмотр
-
RNA Therapeutics Market Accelerates with Breakthroughs in Precision MedicineGlobal Executive Summary RNA Therapeutics Market: Size, Share, and Forecast During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine While preparing the first class RNA Therapeutics...0 Комментарии 0 Поделились 364 Просмотры 0 предпросмотр
Расширенные страницы
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek
